{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:21:34Z","timestamp":1758633694097},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,7]],"date-time":"2011-09-07T00:00:00Z","timestamp":1315353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s12253-011-9441-4","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T19:05:34Z","timestamp":1315335934000},"page":"1-10","source":"Crossref","is-referenced-by-count":5,"title":["Role of Organ Transplantation in the Treatment of Malignancies \u2013 Hepatocellular Carcinoma as the Most Common Tumour Treated with Transplantation"],"prefix":"10.1007","volume":"18","author":[{"given":"Gyula","family":"V\u00e9gs\u0151","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9nes","family":"G\u00f6r\u00f6g","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imre","family":"Feh\u00e9rv\u00e1ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal\u00e1zs","family":"Nemes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Doros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00f3bert Mikl\u00f3s","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"K\u00f3bori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,7]]},"reference":[{"key":"9441_CR1","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1097\/01.tp.0000186382.81130.ba","volume":"80","author":"JF Buell","year":"2005","unstructured":"Buell JF, Gross TG, Woodle ES (2005) Malignancy after transplantation. Transplantation 80:S254\u2013S264","journal-title":"Transplantation"},{"key":"9441_CR2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1503\/cmaj.051291","volume":"173","author":"G Knoll","year":"2005","unstructured":"Knoll G, Cockfield S, Blydt-Hansen T et al (2005) Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ 173:1181\u20131184","journal-title":"CMAJ"},{"key":"9441_CR3","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1200\/JCO.2004.12.188","volume":"22","author":"M Perrot De","year":"2004","unstructured":"De Perrot M, Fischer S, Waddel TK et al (2004) Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease. J Clin Oncol 22:4351\u20134356","journal-title":"J Clin Oncol"},{"key":"9441_CR4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/JTO.0b013e31819afdd9","volume":"4","author":"J Mathew","year":"2009","unstructured":"Mathew J, Kratzke RA (2009) Lung cancer and lung transplantation. J Thorac Oncol 4:753\u2013760","journal-title":"J Thorac Oncol"},{"key":"9441_CR5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00001573-200003000-00010","volume":"15","author":"A Gowdamarajan","year":"2000","unstructured":"Gowdamarajan A, Michler RE (2000) Therapy for primary cardiac tumors: is there a role for heart transplantation? Curr Op Cardiol 15:121\u2013126","journal-title":"Curr Op Cardiol"},{"key":"9441_CR6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ejcts.2006.03.034","volume":"29","author":"G Shanmugam","year":"2006","unstructured":"Shanmugam G (2006) Primary cardiac sarcoma. Eur J Cardiothorac Surg 29:925\u2013932","journal-title":"Eur J Cardiothorac Surg"},{"key":"9441_CR7","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1586\/14779072.6.10.1295","volume":"6","author":"A Gupta","year":"2008","unstructured":"Gupta A (2008) Primary cardiac sarcomas. Expert Rev Cardiovasc Ther 6:1295\u20131297","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"9441_CR8","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1053\/jlts.2000.18687","volume":"6","author":"JG O\u2019Grady","year":"2000","unstructured":"O\u2019Grady JG (2000) Treatment options for other hepatic malignancies. Liver Transpl 6:S23\u2013S29","journal-title":"Liver Transpl"},{"key":"9441_CR9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/SLA.0b013e3181afe0ab","volume":"250","author":"F Ito","year":"2009","unstructured":"Ito F, Cho CS, Rikkers LF et al (2009) Hilar cholangiocarcinoma: current management. Ann Surg 250:210\u2013218","journal-title":"Ann Surg"},{"key":"9441_CR10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ciresp.2009.11.005","volume":"87","author":"R Robles","year":"2010","unstructured":"Robles R, Parilla P, S\u00e1nchez-Bueno F et al (2010) Liver transplantation increases R0 resection and survival of patients with a non-disseminated unresectable Klatskin tumour. Cir Esp 87:82\u201388","journal-title":"Cir Esp"},{"key":"9441_CR11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","volume":"242","author":"DJ Rea","year":"2005","unstructured":"Rea DJ, Heimbach JK, Rosen CB et al (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242:451\u2013458","journal-title":"Ann Surg"},{"key":"9441_CR12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1634\/theoncologist.10-4-269","volume":"10","author":"M Hertl","year":"2005","unstructured":"Hertl M, Cosimi AB (2005) Liver transplantation for malignancy. Oncologist 10:269\u2013281","journal-title":"Oncologist"},{"key":"9441_CR13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Pankin","year":"2005","unstructured":"Pankin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"9441_CR14","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3748\/wjg.14.4300","volume":"14","author":"AI Gomaa","year":"2008","unstructured":"Gomaa AI, Khan SA, Toledano MB et al (2008) Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14:4300\u20134308","journal-title":"World J Gastroenterol"},{"key":"9441_CR15","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMsa050467","volume":"353","author":"J He","year":"2005","unstructured":"He J, Gu D, Wu X et al (2005) Major causes of death among men and women in China. N Engl J Med 353:1124\u20131134","journal-title":"N Engl J Med"},{"key":"9441_CR16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000218339","volume":"27","author":"K Sch\u00fctte","year":"2009","unstructured":"Sch\u00fctte K, Bornschein J, Malfertheiner P (2009) Hepatocellular carcinoma\u2014epidemiological trends and risk factor. Dig Dis 27:80\u201392","journal-title":"Dig Dis"},{"key":"9441_CR17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329\u2013338","journal-title":"Semin Liver Dis"},{"key":"9441_CR18","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/cncr.25044","volume":"116","author":"CY Hsu","year":"2010","unstructured":"Hsu CY, Hsia CY, Huang YH et al (2010) Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models. Cancer 116:3006\u20133014","journal-title":"Cancer"},{"key":"9441_CR19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.medcli.2008.11.024","volume":"132","author":"A Forner","year":"2009","unstructured":"Forner A, Ayuso C, Real MB et al (2009) Diagnosis and treatment of hepatocellular carcinoma. Med Clin 132:272\u2013286","journal-title":"Med Clin"},{"key":"9441_CR20","first-page":"15","volume":"19","author":"M Dank","year":"2009","unstructured":"Dank M (2009) New possibilities in the management of hepatocellular carcinoma. Lege Artis Med 19:15\u201321","journal-title":"Lege Artis Med"},{"key":"9441_CR21","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/hep.22506","volume":"48","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48:1312\u20131327","journal-title":"Hepatology"},{"key":"9441_CR22","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1016\/S1590-8658(10)60512-9","volume":"42","author":"S Tremosini","year":"2010","unstructured":"Tremosini S, Reig M, de Lope CD et al (2010) Treatment of early hepatocellular carcinoma: towards personalized therapy. Dig Liver Dis 42:S242\u2013S248","journal-title":"Dig Liver Dis"},{"key":"9441_CR23","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020\u20131022","journal-title":"Hepatology"},{"key":"9441_CR24","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2008.02.090","volume":"134","author":"HB El-Serag","year":"2008","unstructured":"El-Serag HB, Marrero JA, Rudolph L et al (2008) Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134:1752\u20131763","journal-title":"Gastroenterology"},{"key":"9441_CR25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00535-007-2141-x","volume":"43","author":"Y Ishizaki","year":"2008","unstructured":"Ishizaki Y, Kawasaki S (2008) The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J Gastroenterol 43:18\u201326","journal-title":"J Gastroenterol"},{"key":"9441_CR26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/BF01659064","volume":"15","author":"B Ringe","year":"1991","unstructured":"Ringe B, Pichlmayr R, Wittekind C et al (1991) Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 15:270\u2013285","journal-title":"World J Surg"},{"key":"9441_CR27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 334:693\u2013699","journal-title":"N Engl J Med"},{"key":"9441_CR28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/lt.20012","volume":"10","author":"P Sharma","year":"2004","unstructured":"Sharma P, Balan V, Hernandez JL et al (2004) Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 10:36\u201341","journal-title":"Liver Transpl"},{"key":"9441_CR29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(89)92101-6","volume":"2","author":"S Raia","year":"1989","unstructured":"Raia S, Nery JR, Mies S (1989) Liver transplantation from live donors. Lancet 2:497","journal-title":"Lancet"},{"key":"9441_CR30","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(94)92450-3","volume":"343","author":"Y Hashikura","year":"1994","unstructured":"Hashikura Y, Makuuchi M, Kawasaki S et al (1994) Successful living-related partial liver transplantation to an adult patient. Lancet 343:1233\u20131234","journal-title":"Lancet"},{"key":"9441_CR31","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.3748\/wjg.15.5511","volume":"15","author":"S Tanwar","year":"2009","unstructured":"Tanwar S, Khan SA, Grover VPB et al (2009) Liver transplantation for hepatocellular carcinoma. World J Gastroenterol 15:5511\u20135516","journal-title":"World J Gastroenterol"},{"key":"9441_CR32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1015-9584(10)60011-5","volume":"33","author":"HY Chung","year":"2010","unstructured":"Chung HY, Chan SC, Lo CM et al (2010) Strategies for widening liver donor pool. Asian J Surg 33:63\u201369","journal-title":"Asian J Surg"},{"key":"9441_CR33","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/01.TP.0000046532.44975.57","volume":"15","author":"VH Villa de","year":"2003","unstructured":"de Villa VH, Lo CM, Chen CH (2003) Ethics and rationale of living-donor liver transplantation in Asia. Transplantation 15:S2\u2013S5","journal-title":"Transplantation"},{"key":"9441_CR34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00534-007-1296-4","volume":"15","author":"A Taketomi","year":"2008","unstructured":"Taketomi A, Soejima Y, Yoshizumi T et al (2008) Liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 15:124\u2013130","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"9441_CR35","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/lt.21445","volume":"14","author":"SG Lee","year":"2008","unstructured":"Lee SG, Hwang S, Moon DB et al (2008) Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl 14:935\u2013945","journal-title":"Liver Transpl"},{"key":"9441_CR36","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/lt.21940","volume":"15","author":"K Vakili","year":"2009","unstructured":"Vakili K, Pomposelli JJ, Cheah YL et al (2009) Living donor liver transplantation for hepatocellular carcinoma: increased recurrence but improved survival. Liver Transpl 15:1861\u20131866","journal-title":"Liver Transpl"},{"key":"9441_CR37","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/01.TP.0000047029.02806.16","volume":"75","author":"S Kaihara","year":"2003","unstructured":"Kaihara S, Kiuchi T, Ueda M et al (2003) Living-donor liver transplantation for hepatocellular carcinoma. Transplantation 75:S37\u2013S40","journal-title":"Transplantation"},{"key":"9441_CR38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000137129.98894.42","volume":"240","author":"S Todo","year":"2004","unstructured":"Todo S, Furukawa H, Japanese Study Group on Organ Transplantation (2004) Living donor liver transplantation for adult patients with hepatocellular carcinoma. Experience in Japan. Ann Surg 240:451\u2013461","journal-title":"Ann Surg"},{"key":"9441_CR39","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/j.1600-6143.2007.01802.x","volume":"7","author":"RA Fisher","year":"2007","unstructured":"Fisher RA, Kulik LM, Freise CE et al (2007) Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 7:1601\u20131608","journal-title":"Am J Transplant"},{"key":"9441_CR40","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1440-1746.2010.06335.x","volume":"25","author":"MF Silva","year":"2010","unstructured":"Silva MF, Wigg AJ (2010) Current controversies surrounding liver transplantation for hepatocellular carcinoma. J Gastoenterol Hepatol 25:1217\u20131226","journal-title":"J Gastoenterol Hepatol"},{"key":"9441_CR41","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1440-1746.2010.06418.x","volume":"25","author":"T Kaido","year":"2010","unstructured":"Kaido T, Uemoto S (2010) Does living donation have adventages over deceased donation in liver transplantation ? J Gastroenterol Hepatol 25:1598\u20131603","journal-title":"J Gastroenterol Hepatol"},{"key":"9441_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.trre.2009.10.002","volume":"24","author":"K Washburn","year":"2010","unstructured":"Washburn K (2010) Model for end stage liver disease and hepatocellular carcinoma: a moving target. Transplant Rev 24:11\u201317","journal-title":"Transplant Rev"},{"key":"9441_CR43","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1002\/lt.21329","volume":"13","author":"K Rayaie","year":"2007","unstructured":"Rayaie K, Feng S (2007) Allocation policy for hepatocellular carcinomain the MELD era: room for improvement ? Liver Transpl 13:S36\u2013S43","journal-title":"Liver Transpl"},{"key":"9441_CR44","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1111\/j.1600-6143.2006.01509.x","volume":"6","author":"M Lesurtel","year":"2006","unstructured":"Lesurtel M, Mullhaupt B, Pestalozzi BC et al (2006) Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. Am J Transpl 6:2644\u20132650","journal-title":"Am J Transpl"},{"key":"9441_CR45","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/lt.21018","volume":"12","author":"PM Lopez","year":"2006","unstructured":"Lopez PM, Villanueva A, Roayaie S et al (2006) Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal. Liver Transpl 12:1747\u20131754","journal-title":"Liver Transpl"},{"key":"9441_CR46","first-page":"306A","volume":"50","author":"PG Northup","year":"2009","unstructured":"Northup PG, Argo CK, Shah NL et al (2009) Locoregional therapy of T1 hepatocellular carcinomas is associated with increased transplant waiting list mortality and offers no additional post-transplant survival. Hepatology 50:306A","journal-title":"Hepatology"},{"key":"9441_CR47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.50.1.123","volume":"50","author":"JM Llovet","year":"2002","unstructured":"Llovet JM, Mas X, Aponte JJ et al (2002) Cost-effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut 50:123\u2013128","journal-title":"Gut"},{"key":"9441_CR48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1432-2277.2009.00980.x","volume":"23","author":"C Sandrousi","year":"2009","unstructured":"Sandrousi C, Dawson LA, Lee M et al (2009) Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma. Transpl Int 23:299\u2013306","journal-title":"Transpl Int"},{"key":"9441_CR49","unstructured":"Lau WY, Lai EC, Leung TW (2010) Current role of selective internal irradiation with Yttrium-90 microspheres in the management of hepatocellular carcioma: a systematic review. Int J Radiat Oncol Biol Phys. doi: 10.016\/j.ijrobp. 2010.06.010"},{"key":"9441_CR50","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advenced hepatocellular carcinoma. N Engl J Med 359:378\u2013390","journal-title":"N Engl J Med"},{"key":"9441_CR51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hep.23260","volume":"51","author":"A Vitale","year":"2010","unstructured":"Vitale A, Volk ML, Pastorelli D et al (2010) Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology 51:165\u2013173","journal-title":"Hepatology"},{"key":"9441_CR52","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1432-2277.2010.01111.x","volume":"23","author":"S Bhoori","year":"2010","unstructured":"Bhoori S, Sposito C, Germini A et al (2010) The challanges of liver transplantation for hepatocellular carcinoma on cirrhosis. Transplant Int 23:712\u2013722","journal-title":"Transplant Int"},{"key":"9441_CR53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.23332","volume":"51","author":"M Navasa","year":"2010","unstructured":"Navasa M, Bruix J (2010) Multifaced perspective of the waiting list for liver transplantation: the value of pharmacokinetic models. Hepatology 51:12\u201315","journal-title":"Hepatology"},{"key":"9441_CR54","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.23702","volume":"52","author":"IA Rowe","year":"2010","unstructured":"Rowe IA (2010) Sorafenib therapy in patients with hepatocellular carcinoma before liver transplantation. Hepatology 52:1171\u20131172","journal-title":"Hepatology"},{"key":"9441_CR55","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1600-6143.2008.02409.x","volume":"8","author":"M Ravaioli","year":"2008","unstructured":"Ravaioli M, Grazi GL, Piscaglia F et al (2008) Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 8:2547\u20132557","journal-title":"Am J Transplant"},{"key":"9441_CR56","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2036.2009.04167.x","volume":"31","author":"JW Jang","year":"2010","unstructured":"Jang JW, You CR, Kim CW et al (2010) Benefit of downsizing hepatocellular carcinoma in a liver transplant population. Aliment Pharmacol Ther 31:415\u2013423","journal-title":"Aliment Pharmacol Ther"},{"key":"9441_CR57","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.transproceed.2007.06.015","volume":"39","author":"S Bhoori","year":"2007","unstructured":"Bhoori S, Schiavo M, Russo A et al (2007) First-line treatment for hepatocellular carcinoma: resection or transplantation ? Transplant Proc 39:2271\u20132273","journal-title":"Transplant Proc"},{"key":"9441_CR58","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/j.1600-6143.2008.02351.x","volume":"8","author":"FY Yao","year":"2008","unstructured":"Yao FY (2008) Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Am J Transpl 8:1982\u20131989","journal-title":"Am J Transpl"},{"key":"9441_CR59","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/lt.21576","volume":"14","author":"M Silva","year":"2008","unstructured":"Silva M, Moya A, Berenguer M et al (2008) Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Liver Transpl 14:1449\u20131460","journal-title":"Liver Transpl"},{"key":"9441_CR60","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1111\/j.1600-6143.2007.01965.x","volume":"7","author":"FY Yao","year":"2007","unstructured":"Yao FY, Xiao L, Bass NM et al (2007) Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 7:2587\u20132596","journal-title":"Am J Transplant"},{"key":"9441_CR61","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/SLA.0b013e318148c704","volume":"246","author":"JP Duffy","year":"2007","unstructured":"Duffy JP, Vardanian A, Benjamin E et al (2007) Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 246:502\u2013511","journal-title":"Ann Surg"},{"key":"9441_CR62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","volume":"10","author":"V Mazzaferro","year":"2009","unstructured":"Mazzaferro V, Llovet JM, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35\u201343","journal-title":"Lancet Oncol"},{"key":"9441_CR63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1470-2045(09)70053-1","volume":"10","author":"GC Sotiropoulos","year":"2009","unstructured":"Sotiropoulos GC, Molmenti EP, Lang H (2009) Milan criteria, up-to-seven criteria, and the illusion of a rescue package for patients with liver cancer. Lancet Oncol 10:207\u2013208","journal-title":"Lancet Oncol"},{"key":"9441_CR64","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/hep.22693","volume":"49","author":"C Toso","year":"2009","unstructured":"Toso C, Asthana S, Bigam DL et al (2009) Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 49:832\u2013838","journal-title":"Hepatology"},{"key":"9441_CR65","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/lt.21281","volume":"13","author":"T Ito","year":"2007","unstructured":"Ito T, Takada Y, Ueda M et al (2007) Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 13:1637\u20131644","journal-title":"Liver Transpl"},{"key":"9441_CR66","doi-asserted-by":"crossref","unstructured":"Hwang S, Lee SG, Belghiti J (2009) Liver transplantation for HCC: its role: Eastern and Western perspectives. J Hepatobiliary Pancreat Surg. doi: 10.1007\/s00534-009-0241-0","DOI":"10.1007\/s00534-009-0241-0"},{"key":"9441_CR67","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000106910","volume":"25","author":"Y Sugawara","year":"2007","unstructured":"Sugawara Y, Tamura S, Makuuchi M (2007) Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 25:310\u2013312","journal-title":"Dig Dis"},{"key":"9441_CR68","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/01.tp.0000259015.46798.ec","volume":"83","author":"Y Soejima","year":"2007","unstructured":"Soejima Y, Taketomi Y, Yoshizumi T et al (2007) Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 83:893\u2013899","journal-title":"Transplantation"},{"key":"9441_CR69","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1002\/lt.21334","volume":"13","author":"S Todo","year":"2007","unstructured":"Todo S, Furukawa H, Tada M, Japanese Liver Transplantation Study Group (2007) Extending indication: role of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 13:S48\u2013S54","journal-title":"Liver Transpl"},{"key":"9441_CR70","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000106911","volume":"25","author":"CH Kwon","year":"2007","unstructured":"Kwon CH, Kim DJ, Han YS et al (2007) HCC in living donor liver transplantation: can we expand the Milan criteria ? Dig Dis 25:313\u2013319","journal-title":"Dig Dis"},{"key":"9441_CR71","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jhep.2002.32089","volume":"35","author":"J Bruix","year":"2002","unstructured":"Bruix J, Llovet JM (2002) Prognostic prediction and treatment strategies in hepatocellular carcinoma. Hepatology 35:519\u2013524","journal-title":"Hepatology"},{"key":"9441_CR72","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1478-3231.2010.02413.x","volume":"1","author":"J Belghiti","year":"2011","unstructured":"Belghiti J, Durand F (2011) Criteria for liver transplantation for hepatocellular carcinoma: what is an acceptable outcome ? Liver Int Suppl 1:161\u2013163. doi: 10.1111\/j.1478-3231.2010.024113.x","journal-title":"Liver Int Suppl"},{"key":"9441_CR73","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.20020","volume":"1","author":"PH Hayashi","year":"2004","unstructured":"Hayashi PH, Trotter JF, Forman L et al (2004) Impact of transplant diagnosis of hepatocellular carcinoma on cadaveric liver allocation in the era of MELD score. Liver Transpl 1:42\u201348","journal-title":"Liver Transpl"},{"key":"9441_CR74","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-6143.2009.02750.x","volume":"10","author":"E Vibert","year":"2010","unstructured":"Vibert E, Azoulay D, Hoti E et al (2010) Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant 10:129\u2013137","journal-title":"Am J Transplant"},{"key":"9441_CR75","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jso.20655","volume":"95","author":"K Shirabe","year":"2007","unstructured":"Shirabe K, Itoh S, Yoshizumi Y et al (2007) The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma\u2013with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 95:253\u2013240","journal-title":"J Surg Oncol"},{"key":"9441_CR76","first-page":"299","volume":"63","author":"T Fujikawa","year":"2009","unstructured":"Fujikawa T, Shiraha H, Yamamoto K (2009) Significance of des-gamma-carboxy prothrombin production in hepatocellular carcinoma. Acta Med Okayama 63:299\u2013304","journal-title":"Acta Med Okayama"},{"key":"9441_CR77","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.transproceed.2004.12.030","volume":"37","author":"M Shimada","year":"2005","unstructured":"Shimada M, Yonemura Y, Ijichi H et al (2005) Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value. Transplant Proc 37:1177\u20131179","journal-title":"Transplant Proc"},{"key":"9441_CR78","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2967\/jnumed.108.060574","volume":"50","author":"JW Lee","year":"2009","unstructured":"Lee JW, Paeng JC, Kang KW et al (2009) Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J Nucl Med 50:682\u2013687","journal-title":"J Nucl Med"},{"key":"9441_CR79","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/hep.23437","volume":"51","author":"C Toso","year":"2010","unstructured":"Toso C, Merani S, Bigam DL et al (2010) Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. Hepatology 51:1237\u20131243","journal-title":"Hepatology"},{"key":"9441_CR80","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-07-4774","volume":"14","author":"Z Wang","year":"2008","unstructured":"Wang Z, Zhou J, Fan J et al (2008) Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma. Clin Cancer Res 14:5124\u20135130","journal-title":"Clin Cancer Res"},{"key":"9441_CR81","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2010.01.025","volume":"52","author":"S Bhoori","year":"2010","unstructured":"Bhoori S, Toffanin S, Sposito C et al (2010) Personalized molecular targeted therapy in advenced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle. J Hepatol 52:771\u2013775","journal-title":"J Hepatol"},{"key":"9441_CR82","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.3748\/wjg.v16.i43.5518","volume":"16","author":"Y Wang","year":"2010","unstructured":"Wang Y, Speeg KV, Washburn WK et al (2010) Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: a case report. World J Gastroenterol 16:5518\u20135522","journal-title":"World J Gastroenterol"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-011-9441-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-011-9441-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-011-9441-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T06:53:02Z","timestamp":1686293582000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-011-9441-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,7]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["9441"],"URL":"https:\/\/doi.org\/10.1007\/s12253-011-9441-4","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,7]]}}}